If the proposed Sun-Ranbaxy merger goes through (#msg-100133777), ABT will become the #2 drug company in India. ABT, which sells branded generics, is currently #1 in India with a 7% share of a highly-fragmented market.
Price caps will be lifted for 280 medicines made by Western drug companies and 250 Chinese patent drugs, the National Development and Reform Commission, China's economic planning body, said in a statement Thursday.
…The pricing reversal comes as some manufacturers—aiming to meet low-cost standards—cut corners on production, exposing consumers to safety risks, said Helen Chen, a Shanghai-based partner and director of L.E.K. Consulting. medication. "It means the Commission recognizes that forcing prices down and focusing purely on price does sacrifice drug safety, quality and availability," said Ms. Chen.
The last thing the neurologist said to me as I hobbled toward the door with my prescription for painkillers in hand was "be careful where you get that script filled, the market is full of counterfeits."
…It's not known exactly how many medications sold in Russia are counterfeit. The government says it's as low between 3-4 percent while random surveys of drugs on pharmacy shelves across the country have shown that as much as 27 percent of the medications stocked are fakes.
These days globally the market is thought to be worth anywhere between $70 billion-$200 billion… Another thing that makes manufacturing counterfeits attractive, aside from the lucrative returns, is that often the penalties are quite low. In some cases there are fines or short jail terms.
…What is also interesting about that example is that shows manufacturers are diversifying. They're no longer just producing the so-called block buster drugs like Viagra and the cholesterol medication, Lipitor, but are now making more than 100 types of [counterfeit] drugs ranging including blood pressure and other heart medications, painkillers, anti-inflammatories, cold and flu drugs…
Fake drugs are expected to generate $95 billion in global sales this year, up 26% from $75 billion in 2010, according to the Center for Medicine in the Public Interest, a New York-based research group partly funded by the pharmaceutical industry. In many developing countries…counterfeit drugs account for about 30% of…pharmaceutical sales…
Hence the strong allure of drugs made by companies with a respected name.